Cases of Ischemic Optic Neuropathy Associated With Phosphodiesterase-5 Inhibitor Use Reported to the Food and Drug Administration Adverse Event Reporting System-Reference-Cited by-同舟云学术

Cases of Ischemic Optic Neuropathy Associated With Phosphodiesterase-5 Inhibitor Use Reported to the Food and Drug Administration Adverse Event Reporting System

Published:2016-06 Issue:2 Volume:36 Page:221-222
ISSN:1070-8022
Container-title:Journal of Neuro-Ophthalmology
language:en
Short-container-title:

Author:

Pomeranz Howard D.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Clinical Neurology,Ophthalmology

Reference5 articles.

1. The relationship between phosphodiesterase-5 inhibitors and nonarteritic anterior ischemic optic neuropathy;Pomeranz;J Neuroophthalmol,2016

2. Are erectile dysfunction medications causally related to nonarteritic anterior ischemic optic neuropathy?;Lee;J Neuroophthalmol,2016

3. Sildenafil (Viagra) associated anterior ischemic optic neuropathy;Egan;Arch Ophthalmol,2000

4. Sildenafil-associated nonarteritic anterior ischemic optic neuropathy;Pomeranz;Ophthalmology,2002

5. Ischemic optic neuropathy in a child;Sivaswamy;Pediatr Neurol,2007

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety profile and signal detection of phosphodiesterase type 5 inhibitors for erectile dysfunction: a Food and Drug Administration Adverse Event Reporting System analysis;Sexual Medicine;2023-10-01

2. Phase 4 Studies on Phosphodiesterase 5 Inhibitors;JAMA Ophthalmology;2022-05-01

3. Sildenafil in ophthalmology: An update;Survey of Ophthalmology;2021-06

4. Risk of nonarteritic ischaemic optic neuropathy with phosphodiesterase type 5 inhibitors: a systematic review and meta‐analysis;Acta Ophthalmologica;2019-09-27

5. The Association Between Phosphodiesterase Type 5 Inhibitor Use and Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Meta-Analysis;Sexual Medicine;2018-09